Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

NCT01370694 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated for business reasons.

Conditions

Follicular Lymphoma

Interventions

DRUG: MK-8808
DRUG: cyclophosphamide
DRUG: vincristine
DRUG: prednisolone

Sponsor

Merck Sharp & Dohme LLC